Bellwether Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-86
Closed -$6K 564
2021
Q2
$6K Sell
86
-50
-37% -$3.49K ﹤0.01% 297
2021
Q1
$7K Buy
+136
New +$7K ﹤0.01% 275